• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Vitamin B12 and folic acid in chronic kidney failure and after kidney transplantation].

作者信息

Mydlík M, Machánová I, Derzsiová K, Pribylincová V, Reznícek J

机构信息

IV. Interná klinika fakultná nemocnica s poliklinikou, Kosice.

出版信息

Cas Lek Cesk. 1991 Jan 18;130(3):84-7.

PMID:2004394
Abstract

Vitamin B12 in plasma, folic acid in plasma and erythrocytes were examined in 11 patients in the polyuric stage of chronic renal failure without dialyzation treatment, in 38 patients included in a long-term dialyzation programme before and after 3 months' oral administration of folic acid--(2 X 5 mg week)--and in 23 patients after transplantation of the kidneys. In none of the examined groups vitamin B12) and folic acid deficiency in plasma was detected. A reduced folic acid level in erythrocytes, but still in the reference range, was found in patients in the long-term dialyzation programme without supplementation. Supplementation with folic acid increased its concentration in plasma 4.5 times and in red cells 5.5 times. Haemodialysis did not influence the concentration of the examined indicators in plasma and red cells. According to the recorded results it is not necessary to supplement patients in long-term dialyzation programme and after renal transplantation with vitamin B12 and folic acid, if their dietary protein intake is not restricted.

摘要

相似文献

1
[Vitamin B12 and folic acid in chronic kidney failure and after kidney transplantation].
Cas Lek Cesk. 1991 Jan 18;130(3):84-7.
2
[The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].[降低血浆同型半胱氨酸水平对慢性肾衰竭血液透析患者血栓形成活性某些参数的影响]
Ann Acad Med Stetin. 2004;50(1):87-95.
3
[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].[透析患者高同型半胱氨酸血症的治疗:叶酸还是高流量聚砜膜?]
Acta Med Croatica. 2006 Jun;60(3):201-8.
4
Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.补充叶酸和维生素B12降低血液透析患者的基因组损伤水平
Nephrol Dial Transplant. 2008 Oct;23(10):3272-9. doi: 10.1093/ndt/gfn254. Epub 2008 May 9.
5
[Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].[补充叶酸的血液透析患者高同型半胱氨酸血症的发生率]
Orv Hetil. 2002 Jul 7;143(27):1635-40.
6
Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.关于大剂量叶酸、维生素B12和B6、静脉注射亚叶酸和丝氨酸治疗终末期肾病高同型半胱氨酸血症的对照试验。
J Nephrol. 2003 Jul-Aug;16(4):522-34.
7
[Folic acid levels in patients with compensated renal failure and during long-term haemodialysis (author's transl)].代偿性肾衰竭患者及长期血液透析患者的叶酸水平(作者译)
Dtsch Med Wochenschr. 1977 Dec 9;102(49):1808-13. doi: 10.1055/s-0028-1105603.
8
[Hematologic changes in patients under long-term hemodialysis and hemofiltration treatment with special reference to serum concentrations of folic acid and vitamin B 12].[长期血液透析和血液滤过治疗患者的血液学变化,特别提及叶酸和维生素B12的血清浓度]
Schweiz Med Wochenschr. 1984 Jan 14;114(2):48-53.
9
Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.终末期肾病患者高同型半胱氨酸血症对补充叶酸的反应。
Clin Nephrol. 1999 Feb;51(2):108-15.
10
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.对于冠心病患者,叶酸和维生素B12在降低空腹血浆同型半胱氨酸浓度方面比维生素B6更有效。
Eur J Clin Nutr. 2004 Mar;58(3):481-7. doi: 10.1038/sj.ejcn.1601834.